Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06518941 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

An Open Trial of a Novel Pharmacotherapy for Habit Modification in Anorexia Nervosa

StatusNot Yet Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 11 months later Jun 2027 → Jun 2028
See other at-risk trials from New York State Psychiatric Institute

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Jun 2027 to Jun 2028
    • Start date: Jun 2026 to Jan 2027
    • Study completion pushed from Dec 2027 to Dec 2028
    v5
  2. Primary completion date: Dec 2025 to Jun 2027
    • Start date: Jun 2025 to Jun 2026
    • Study completion date: Jun 2026 to Dec 2027
    • Site contact updated
    v4
  3. Start date: Dec 2024 to Jun 2025
    • Study completion date: Dec 2025 to Jun 2026
    • Site contact updated
    v3
  4. Primary endpoints: 1 to 2
    • Secondary endpoints: 1 to 2
    • Eligibility criteria expanded, about 2 words
    • Study description shortened, about 4 words
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to test the feasibility and tolerability of donepezil in a small group of patients with anorexia nervosa (AN). Study participants will be receiving care at the New York State Psychiatric Institute Eating Disorders Unit. Study medication will be increased from 1 mg per day to a maximum of 5 mg per day for up to 8 weeks. Participants will be closely monitored for side effects by a research psychiatrist every week, in addition to the regular clinical monitoring they receive during inpatient treatment. The study will also include assessments of habit strength to measure any changes in maladaptive eating habits over the course of the treatment.
Trial Details
NCT Number NCT06518941
Lead Sponsor New York State Psychiatric Institute
Conditions
(from sponsor)		 Anorexia Nervosa
Related terms Anorexia, Anorexia Nervosa, Feeding and Eating Disorders, Habits
Enrollment 10 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov